Southeast Renal Research Institute

🇺🇸United States
Ownership
Private
Established
2008-01-01
Employees
-
Market Cap
-
Website
http://www.serri.net

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

First Posted Date
2017-04-11
Last Posted Date
2017-09-11
Lead Sponsor
Southeast Renal Research Institute
Target Recruit Count
30
Registration Number
NCT03106948
Locations
🇺🇸

Southeast Renal Research Institute, Chattanooga, Tennessee, United States

Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome

First Posted Date
2017-02-03
Last Posted Date
2021-02-17
Lead Sponsor
Southeast Renal Research Institute
Registration Number
NCT03042637
Locations
🇺🇸

Nephronet, Chattanooga, Tennessee, United States

Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

First Posted Date
2013-08-14
Last Posted Date
2017-01-24
Lead Sponsor
Southeast Renal Research Institute
Target Recruit Count
53
Registration Number
NCT01922999
Locations
🇺🇸

Southeast Renal Research Institute, Chattanooga, Tennessee, United States

Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury

First Posted Date
2010-02-23
Last Posted Date
2016-03-28
Lead Sponsor
Southeast Renal Research Institute
Registration Number
NCT01073189
Locations
🇺🇸

Erlanger Medical Center, Chattanooga, Tennessee, United States

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2009-12-09
Last Posted Date
2013-05-31
Lead Sponsor
Southeast Renal Research Institute
Target Recruit Count
15
Registration Number
NCT01028287
Locations
🇺🇸

Southeast Renal Research Institute, Chattanooga, Tennessee, United States

Vitamin D and Carboxy PTH Fragments in Coronary Calcification

First Posted Date
2007-07-17
Last Posted Date
2020-12-23
Lead Sponsor
Southeast Renal Research Institute
Registration Number
NCT00502268
Locations
🇺🇸

Davita East Charlotte Dialysis Unit, Charlotte, North Carolina, United States

Vasodilators and Anti-Oxidant Therapy in Early ATN

Phase 2
Withdrawn
Conditions
First Posted Date
2006-02-03
Last Posted Date
2016-03-28
Lead Sponsor
Southeast Renal Research Institute
Registration Number
NCT00286403
Locations
🇺🇸

Mandeep Grewal, Chattanooga, Tennessee, United States

🇺🇸

Chawala, M. MD, Washington, District of Columbia, United States

© Copyright 2024. All Rights Reserved by MedPath